Case Cluster of RT-PCR COVID-19 Positive Patients with an Unexpected Benign Clinical Course With Vitamin D, Melatonin, Vitamin C, and Viscum Album
Hancock et al.,
Case Cluster of RT-PCR COVID-19 Positive Patients with an Unexpected Benign Clinical Course With Vitamin D,..,
SSRN, doi:10.2139/ssrn.3779211 (Preprint)
Case series of 24 COVID-19 patients (12 confirmed PCR+) treated with vitamin D, vitamin C, and melatonin, showing positive outcomes with no patient having worse than a mild case, including 7 high risk patients.
Hancock et al., 9 Feb 2021, preprint, 4 authors.
Abstract: Vitamin D, Melatonin, Vitamin C, and Viscum Album
iew
ed
Case Cluster of RT-PCR COVID-19 Positive Patients with an Unexpected Benign Clinical Course With
Authors: Mark Hancock MD MPH1, Petra Ketterl MD1, Xavier Vinas2, Paul Werthmann MD3,4,5
Institutions:
HUMANIZING MEDICINE, 135 Maple Street, Building A, Decatur, GA, US
2
Xavier Viñas Design, Decatur, GA, US
3
Center for Complementary Medicine – University of Freiburg, Faculty of Medicine, University of
4
Institute for Applied Epistemology and Medical Methodology at the University of Witten/Herdecke,
Zechenweg 6, D-79111 Freiburg i.Brsg., Germany
Department of General and Visceral Surgery, University Hospital Ulm, Ulm, Germany
pe
5
er
r
Freiburg, Breisacherstr. 115B, 79106 Freiburg, Germany
ev
1
Corresponding author: Mark Hancock MD MPH, HUMANIZING MEDICINE, 135 Maple Street, Building
Pr
ep
rin
tn
ot
A, Decatur, GA, US, mark@humanizingmedicine.com
This preprint research paper has not been peer reviewed. Electronic copy available at: https://ssrn.com/abstract=3779211
Abstract
iew
ed
Background: The SARS-COV-2 global pandemic has been noted to have a differential effect on those
exposed depending on risk factors such as age, diabetes, cardiovascular disease and cancer.
Case presentation: We report a case series of 12 confirmed positive patients and 12 presumptive
positive patients all of whom had either an entirely asymptomatic or relatively mild clinical course. 2
patients had active cancer, 3 patients were cancer survivors, 1 patient without cancer was 74 years
old. All patients were treated early in their disease course with vitamin D loading (50,000iu daily for 3
ev
days), 60 to 240mg melatonin, and 2000mg oral vitamin C. The 6 high risk patients and one 59 year old
patient were treated with at least 2 intravenous doses of vitamin C. The 2 patients with active cancer
received 75 grams of vitamin C (one daily, the other every other day). All of the high risk patients had
er
r
a nearly asymptomatic clinical course and were tested after 10 days and all had a RT PCR for COVID-19
that was negative. The 17 remaining patients also had a relatively benign course though 4 patients (2
in their 20s, 2 in their 50s) received this treatment course later in the course of their illness, these
were notably the only patients who had more than a mild sore throat or low grade fever.
pe
Conclusion: We report these unexpectedly positive clinical outcomes of COVID-19 patients including
patients with different risk factors, under supplemental vitamin C and D and melatonin. These
supplements have a favorable safety profile and are already being suggested as potentially disease
tn
ot
altering therapies in the ongoing COVID-19 pandemic.
Pr
ep
rin
Key Words: COVID-19, Cancer, Vitamin D, Melatonin, Vitamin C
This preprint research paper has not been peer reviewed. Electronic copy available at: https://ssrn.com/abstract=3779211
hancock
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit